Related Experiment Video
Updated: Feb 14, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway
Jing Yang1, Xianyue Ren1, Liping Zhang1
1Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou 510055, China.
Abstract:
Oridonin, a bioactive diterpenoid purified from Rabdosia rubescens, has been shown to possess anticancer capacity in several cancer types. However, its effects on oral squamous cell carcinoma (OSCC) cells remain unclear. This study aimed to investigate the anticancer ability of oridonin in OSCC cells, including proliferation, apoptosis and underlying mechanisms using the OSCC cell lines, UM1 and SCC25. The results showed that oridonin not only inhibited proliferation and clonal formation but also induced G2/M cell cycle arrest and apoptosis in UM1 and SCC25 cells in a dose-dependent manner. Western blot revealed that oridonin treatment increased the ratio of Bax/Bcl-2, and activated the cleavage of caspase-3, caspase-9 and PARP-1. Oridonin also induced G2/M phase arrest in OSCC cells via down-regulating the G2/M transition-related proteins such as cyclin B1 or up-regulating cyclin D1, cyclin D3, P21, p-CDK1 and cyclin A2. In addition, oridonin treatment significantly inhibited the phosphorylation of PI3K and Akt and inhibited tumor growth of OSCC xenograft in nude mice. Taken together, these results suggested that oridonin possesses anti-oral cancer capacity via inhibiting the PI3K/Akt signaling and induce apoptosis and G2/M-phase arrest. Therefore, oridonin may be a potential anticancer drug for the treatment of oral cancer.
Insights
Oridonin, a natural compound, effectively combats oral cancer by inhibiting cell growth, promoting apoptosis, and halting cell cycle progression. It targets key signaling pathways, showing promise as an oral cancer therapeutic.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Oridonin, derived from Rabdosia rubescens, exhibits anticancer properties in various cancer types.
- The therapeutic potential of oridonin against oral squamous cell carcinoma (OSCC) remains largely unexplored.
Purpose of the Study:
- To investigate the anticancer effects of oridonin on OSCC cells.
- To elucidate the underlying molecular mechanisms of oridonin's action in OSCC.
Main Methods:
- Utilized OSCC cell lines (UM1 and SCC25) for in vitro studies.
- Assessed proliferation, apoptosis, cell cycle distribution, and protein expression via Western blot.
- Evaluated the impact of oridonin on PI3K/Akt signaling pathway.
- Investigated oridonin's efficacy in an in vivo OSCC xenograft mouse model.
Main Results:
- Oridonin significantly inhibited OSCC cell proliferation, clonal formation, and induced G2/M cell cycle arrest.
- Treatment with oridonin promoted apoptosis by altering Bax/Bcl-2 ratios and activating caspases (caspase-3, caspase-9) and PARP-1.
- Oridonin modulated G2/M transition proteins (down-regulating cyclin B1; up-regulating cyclin D1, D3, P21, p-CDK1, cyclin A2).
- Oridonin suppressed PI3K/Akt phosphorylation and reduced OSCC tumor growth in vivo.
Conclusions:
- Oridonin demonstrates significant anti-oral cancer activity by inducing apoptosis and G2/M cell cycle arrest.
- The PI3K/Akt signaling pathway is a key target for oridonin's therapeutic effects in OSCC.
- Oridonin represents a promising candidate for the development of novel oral cancer treatments.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

